Publications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (78)

2026

  1. Cannabinoid CB2 receptor drives trastuzumab resistance and predicts durable anti-HER2 response

    Oncogene

  2. PCMT1 generates the C-terminal cyclic imide degron on CRBN substrates

    Nature Chemical Biology, Vol. 22, Núm. 5, pp. 802-812

2025

  1. Contilistat, a New Multitarget Small Polyfunctionalized Indole Derivative

    Synlett, Vol. 36, Núm. 16, pp. 2655-2660

  2. From Diarylsulfides to Diarylamines: New Ebola Virus Entry Inhibitors with Improved Metabolic Stability

    Journal of Medicinal Chemistry, Vol. 68, Núm. 11, pp. 11786-11800

  3. Prenatal Downregulation of CB1 Cannabinoid Receptors in the Mouse Prefrontal Cortex Disrupts Cortical Lamination and Induces a Transcriptional Signature Associated with Social Interaction Deficits

    The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 45, Núm. 42

  4. Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington’s disease models

    Translational Neurodegeneration, Vol. 14, Núm. 1

2024

  1. CB1 receptors in NG2 cells mediate cannabinoid-evoked functional myelin regeneration

    Progress in Neurobiology, Vol. 243

  2. Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases

    Journal of Medicinal Chemistry, Vol. 67, Núm. 18, pp. 16533-16555

  3. GAP43 Located on Corticostriatal Terminals Restrains Novelty-Induced Hyperactivity in Mice

    Journal of Neuroscience, Vol. 44, Núm. 39

  4. The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

    EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783

  5. The endocannabinoid system as a therapeutic target in neuropathic pain: a review

    Expert Opinion on Therapeutic Targets, Vol. 28, Núm. 9, pp. 739-755

2023

  1. Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43

    Nature Communications, Vol. 14, Núm. 1

  2. Endocannabinoid signaling in glioma

    GLIA, Vol. 71, Núm. 1, pp. 127-138

  3. Fatty acids fuelling astroglia and beyond

    Nature Metabolism

  4. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

  5. Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale

    Frontiers in Bioengineering and Biotechnology, Vol. 11

  6. Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43

    Neuropharmacology, Vol. 240

  7. The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice

    Neurobiology of Disease, Vol. 184

2022

  1. Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice

    Cell Death and Disease, Vol. 13, Núm. 7

  2. Paving the Way for Reliable Alzheimer's Disease Blood Diagnosis by Quadruple Electrochemical Immunosensing

    ChemElectroChem, Vol. 9, Núm. 9